Mengchu Wu – CEO, Health Genetech, Taiwan
Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer…
Founded in 2002 as a high throughput and industrial-scale antibody manufacturing, Abnova has diversified and established fully integrated technologies from design to production to catapult innovation and growth in the diagnostic industry. Abnova’s new capabilities include rabbit monoclonal antibody, FISH probe, nanoparticle/nanostructure synthesis, microfluidics, optics, electronics, and automations. Abnova’s facility is ISO13485 and GMP certified for bioreagent and instrument development and manufacturing. Abnova has successfully developed and partnered with global companies in companion diagnostic of lung cancer, point-of-care screening of diabetes, and non-invasive prenatal diagnosis of fetal cell. Abnova also provides these effective turnkey solutions as services to collaborators and customers worldwide.
Contact Information
Add: 9th Fl., No.108, Jhouzih St.,
Neihu District. Taipei City, Taiwan 114
Tel: +886-2-8751-1888
Fax: +886-2-8751-9489
Email: sales@abnova.com
Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer…
Today Su, CEO of Golden Biotechnology, introduces the innovative biotech developing a revolutionary botanical drug derived from the Taiwanese fungus Antrodia Camphorata. The company’s drug, Hocena®, has already received several…
Barry Lam, founder and chairman of Quanta Computer, shares the story of how he built the company into one of the world’s leading electronics and IT manufacturers. Lam then sheds…
With the USA and China locked in a trade war, China’s near neighbour Taiwan – with its strong scientific and technology base, political security and economic reliability – may stand…
Professor Shih-Hua Lin, president of Taiwan’s National Defense Medical Center, shares an overview of the academic and research environment of the institute as well as its role in cultivating the…
Scott Li, deputy director of H Spectrum, a biotech and talent incubator within the Foxconn group, explains the organization’s history and unique role in supporting Foxconn’s transition into healthcare. Li…
William Foreman, president of AmCham Taipei, describes the attractiveness and challenges of Taiwan’s business landscape and the implications of US-China relations on the island. Foreman goes on to highlight the…
Leo Liu, president of GeneReach Biotechnology Corp, shares the story of the diagnostics startup and explains his strategy to transition the company from a leading animal health point-of-care device manufacturer…
Susan Hsu, managing director of Taiwanese data-driven CRO StatPlus, speaks about the key trends impacting Taiwan’s clinical trial environment and goes on to share her views on the increasing attractiveness…
Tony Chung, CEO of Instant NanoBiosensors explains the potential of their fibre-optic biosensor technology – FOPPR, and the commercialization strategy for their light-sensing biomarker analyzer INB-D200. He also highlights Taiwan’s…
Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his…
Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’ most pressing concerns, and outlines the developments of the company which he leads…
See our Cookie Privacy Policy Here
